Powered by

Recro Pharma Added to the Russell 3000® Index

Jun 26, 2017 - GlobeNewswire

MALVERN, Pa., June 26, 2017 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today announced that it was added to the Russell 3000® Index when the Russell Investment Group reconstituted its family of U.S. indexes following market close on June 23, 2017.

Annual Russell indexes reconstitution captures the 4,000 largest US stocks as of the end of May, ranking the...